$316.59 1.3%
WST Stock Price vs. AI Score
Data gathered: November 23

AI Score



Sign up to see AI score

Brand Score Sign up
Employment Score Sign up
User Growth Score Sign up
Fundamental Score Sign up

About West Pharmaceutical Services

West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific.


West Pharmaceutical Services
Price $316.59
Target Price Sign up
Volume 557,000
Market Cap $23.2B
Year Range $276.81 - $395.24
Dividend Yield 0.26%
PE Ratio 47.61
Analyst Rating 100% buy
Industry Biotechnology

In the news


Financial performance View All

Revenue Cost of Revenue Gross Profit Net Income ebitda EPS
Q3 '24743M565M265M136M169M1.850
Q2 '24700M556M230M111M127M1.520
Q1 '24695M465M230M115M158M1.560
Q4 '23724M547M278M137M214M1.830
Q3 '23743M552M288M161M219M2.160

Insider Transactions View All

Witherspoon Charles filed to sell 1,478 shares at $300.
August 21 '24
Witherspoon Charles filed to sell 1,978 shares at $300.
August 21 '24
Green Eric Mark filed to sell 161,898 shares at $304.7.
August 8 '24
Abraham Silji filed to sell 2,860 shares at $330.8.
June 13 '24
Hofmann Thomas W filed to sell 43,565 shares at $365.9.
August 21 '24

Congress Trading View All

Politician Filing Date Type Size
Ro Khanna
Oct 8, 24 Sell $1K - $15K
Jared Moskowitz
Aug 21, 24 Buy $1K - $15K
Jared Moskowitz
Aug 21, 24 Buy $1K - $15K

What is the Market Cap of West Pharmaceutical Services?

The Market Cap of West Pharmaceutical Services is $23.2B.

What is West Pharmaceutical Services' PE Ratio?

As of today, West Pharmaceutical Services' PE (Price to Earnings) ratio is 47.61.

What is the current stock price of West Pharmaceutical Services?

Currently, the price of one share of West Pharmaceutical Services stock is $316.59.

How can I analyze the WST stock price chart for investment decisions?

The WST stock price chart above provides a comprehensive visual representation of West Pharmaceutical Services' stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling West Pharmaceutical Services shares. Our platform offers an up-to-date WST stock price chart, along with technical data analysis and alternative data insights.

Does WST offer dividends to its shareholders?

Yes, West Pharmaceutical Services (WST) offers dividends to its shareholders, with a dividend yield of 0.26%. This dividend yield represents West Pharmaceutical Services' commitment to providing value to its shareholders through both potential capital appreciation and steady income. Investors considering West Pharmaceutical Services in their portfolio should factor in this dividend policy alongside the company's growth prospects and market position.

What are some of the similar stocks of West Pharmaceutical Services?

Some of the similar stocks of West Pharmaceutical Services are Amgen, Gilead Sciences, Catalyst Pharmaceuticals, Inovio Pharmaceuticals, and Anavex Life Sciences.

.
The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.
About Us

AltIndex revolutionizes investing with advanced alternative data analytics, smart insights, and stock alerts, presented in an easy-to-use dashboard powered by comprehensive company data from across the internet.



App download

Legal Disclaimer
The information provided by AltIndex is solely for informational purposes and not a substitute for professional financial advice. Investing in financial markets carries inherent risks, and past performance doesn't guarantee future results. It's crucial to do your research, consult with financial experts, and align your financial objectives and risk tolerance before investing. AltIndex creators and operators are not liable for any financial losses incurred from using this information. Users should exercise caution, seek professional advice, and be prepared for the risks involved in trading and investing in financial assets, only investing what they can afford to lose. The information in this application, derived from publicly available data, is believed to be reliable but may not always be accurate or current. Users should verify information independently and not solely rely on this application for financial decisions. By using AltIndex, you acknowledge that it doesn't offer financial advice and agree to consult a qualified financial advisor before making investment decisions.

© 2024 AltIndex. All rights reserved.